Azaya Therapeutics (Proprietary Nanoparticle Development Platform) is Buildings and Property in United States that focus on Nano particle assets business. They cover business area such as nano particle asset, drug development, nanoparticle, liposomal therapeutic.
-
Nano Particle Assets
-
12500 Network Boulevard
Suite 207
San Antonio, TX 78249
United States
Private
nano particle assetdrug developmentnanoparticleliposomal therapeutic
* We use standard office opening hours in near Azaya Therapeutics (Proprietary Nanoparticle Development Platform)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Azaya Therapeutics (Proprietary Nanoparticle Development Platform) is Buildings and Property business from United States that founded in - ( years old in ), Azaya Therapeutics (Proprietary Nanoparticle Development Platform) business is focusing on Nano Particle Assets.
Azaya Therapeutics (Proprietary Nanoparticle Development Platform) headquarter office and corporate office address is located in 12500 Network Boulevard Suite 207 San Antonio, TX 78249 United States.
Azaya Therapeutics (Proprietary Nanoparticle Development Platform) was founded in United States.
In , Azaya Therapeutics (Proprietary Nanoparticle Development Platform) is currently focus on Nano particle assets sector.
Above is snippet of Google Trends for "Nano particle assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Azaya Therapeutics (Proprietary Nanoparticle Development Platform), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
